Also from this source

You just read:

PROTECT II Interim Results Demonstrate That Impella Is Not Superior to the Intra-Aortic Balloon Pump in Reducing Major Adverse Events in High Risk Patients Receiving Percutaneous Coronary Interventions

News provided by

MAQUET Cardiovascular

Dec 09, 2010, 08:00 EST